help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sherwin, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sherwin, B. B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
*ESTROGENIC SUBSTANCES, CONJUGATED
*ESTRONE
*MEDROXYPROGESTERONE
*TESTOSTERONE
Medline Plus Health Information
*Menopause

Journal of Clinical Endocrinology & Metabolism, Vol 72, 336-343, Copyright © 1991 by Endocrine Society


ARTICLES

The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women

BB Sherwin
Department of Psychology, McGill University, Montreal, Quebec, Canada.

This study investigated the effects of various doses of estrogen and progestin on psychological functioning and sexual behavior of 48 healthy, naturally menopausal women. Subjects were tested before treatment and then randomly assigned to 1 of 4 cyclic sequential hormone regimens for 1 yr. Groups A and C received 0.625 or 1.25 mg conjugated equine estrogen (CEE), respectively, for days 1-25 and 5 mg medroxyprogesterone acetate from days 15-25. Groups B and D were given 0.625 or 1.25 mg CEE, respectively, from days 1-25 and placebo from days 15-25. The higher dose of CEE induced supraphysiological levels of plasma estrone. Plasma testosterone levels were lower in group A when blood was sampled during days 18-20 at a time when they were ingesting both 0.625 mg CEE and 5 mg medroxyprogesterone acetate (P less than 0.05), although these decreases were perhaps too trivial to have affected sexual behavior as was hypothesized. Women in group A also had more negative moods and more psychological symptomatology during treatment compared to those in group D who were receiving 1.25 mg CEE and placebo (P less than 0.01). Regardless of group, sexual desire and arousal were higher during the first 2 weeks of the treatment cycle than during week 4 when no hormones were being ingested (P less than 0.05). These findings demonstrate that the effects of progestin on the central nervous system are reflected by an increase in psychological, exclusive of sexual, symptomatology and are attenuated by a higher estrogen/progestin dose ratio.


This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
B. L. Parry
Perimenopausal Depression
Am J Psychiatry, January 1, 2008; 165(1): 23 - 27.
[Full Text] [PDF]


Home page
JAMAHome page
J. E. Potter
A 60-Year-Old Woman With Sexual Difficulties
JAMA, February 14, 2007; 297(6): 620 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. H. Morrison, R. D. Brinton, P. J. Schmidt, and A. C. Gore
Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women
J. Neurosci., October 11, 2006; 26(41): 10332 - 10348.
[Full Text] [PDF]


Home page
J EndocrinolHome page
J Bancroft
The endocrinology of sexual arousal
J. Endocrinol., September 1, 2005; 186(3): 411 - 427.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Zhao, H. Lorenc, H. Stephenson, Y. J. Wang, D. Witherspoon, B. Katzenellenbogen, D. Pfaff, and N. Vasudevan
Thyroid hormone can increase estrogen-mediated transcription from a consensus estrogen response element in neuroblastoma cells
PNAS, March 29, 2005; 102(13): 4890 - 4895.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
Depression
Obstet. Gynecol., October 1, 2004; 104(4_suppl): 49S - 55S.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Pazol, M. E. Wilson, and K. Wallen
Medroxyprogesterone Acetate Antagonizes the Effects of Estrogen Treatment on Social and Sexual Behavior in Female Macaques
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2998 - 3006.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
B. B Sherwin and J. McGill
Oestrogen plus progestin doubles the risk of dementia in post-menopausal women
Evid. Based Ment. Health, November 1, 2003; 6(4): 111 - 111.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Bjorn, I. Sundstrom-Poromaa, M. Bixo, S. Nyberg, G. Backstrom, and T. Backstrom
Increase of Estrogen Dose Deteriorates Mood during Progestin Phase in Sequential Hormonal Therapy
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2026 - 2030.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Yokomaku, T. Numakawa, Y. Numakawa, S. Suzuki, T. Matsumoto, N. Adachi, C. Nishio, T. Taguchi, and H. Hatanaka
Estrogen Enhances Depolarization-Induced Glutamate Release through Activation of Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase in Cultured Hippocampal Neurons
Mol. Endocrinol., May 1, 2003; 17(5): 831 - 844.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. B. Sherwin
Estrogen and Cognitive Functioning in Women
Endocr. Rev., April 1, 2003; 24(2): 133 - 151.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
B. Breuer, C. Martucci, S. Wallenstein, A. Likourezos, L. S. Libow, A. Peterson, and B. Zumoff
Relationship of Endogenous Levels of Sex Hormones to Cognition and Depression in Frail, Elderly Women
Am J Geriatr Psychiatry, June 1, 2002; 10(3): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. M. Rice, A. B. Graves, S. M. McCurry, L. E. Gibbons, J. D. Bowen, W. C. McCormick, and E. B. Larson
Postmenopausal Estrogen and Estrogen-Progestin Use and 2-Year Rate of Cognitive Change in a Cohort of Older Japanese American Women: The Kame Project
Arch Intern Med, June 12, 2000; 160(11): 1641 - 1649.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
A. G. Herzog
Psychoneuroendocrine Aspects of Temporolimbic Epilepsy: Part I. Brain, Reproductive Steroids, and Emotions
Psychosomatics, April 1, 1999; 40(2): 95 - 101.
[Abstract] [Full Text]


Home page
Arch Pediatr Adolesc MedHome page
L. D. Dorn, S. F. Hitt, and D. Rotenstein
Biopsychological and Cognitive Differences in Children With Premature vs On-Time Adrenarche
Arch Pediatr Adolesc Med, February 1, 1999; 153(2): 137 - 146.
[Abstract] [Full Text] [PDF]


Home page
Transcultural PsychiatryHome page
D. A. Charney
The Psychoendocrinology of Menopause in Cross-Cultural Perspective
Transcultural Psychiatry, January 1, 1996; 33(4): 413 - 434.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society